408 related articles for article (PubMed ID: 10945918)
1. Biotech pharmaceuticals and biotherapy: an overview.
Steinberg FM; Raso J
J Pharm Pharm Sci; 1998; 1(2):48-59. PubMed ID: 10945918
[TBL] [Abstract][Full Text] [Related]
2. Introduction to gene technology.
Ritschel WA; Forusz H
Methods Find Exp Clin Pharmacol; 1994 Sep; 16(7):453-67. PubMed ID: 7885071
[TBL] [Abstract][Full Text] [Related]
3. Biopharmaceuticals in China.
Hu X; Ma Q; Zhang S
Biotechnol J; 2006 Nov; 1(11):1215-24. PubMed ID: 17089435
[TBL] [Abstract][Full Text] [Related]
4. Biopharmaceuticals derived from genetically modified plants.
Goldstein DA; Thomas JA
QJM; 2004 Nov; 97(11):705-16. PubMed ID: 15496527
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibody successes in the clinic.
Reichert JM; Rosensweig CJ; Faden LB; Dewitz MC
Nat Biotechnol; 2005 Sep; 23(9):1073-8. PubMed ID: 16151394
[TBL] [Abstract][Full Text] [Related]
6. Gene technology: chances for diagnosis and therapy.
Werner RG
Methods Find Exp Clin Pharmacol; 1994 Sep; 16(7):525-37. PubMed ID: 7885080
[TBL] [Abstract][Full Text] [Related]
7. Plants as bioreactors for biopharmaceuticals: regulatory considerations.
Miele L
Trends Biotechnol; 1997 Feb; 15(2):45-50. PubMed ID: 9081298
[TBL] [Abstract][Full Text] [Related]
8. [Therapeutic applications of genetic engineering].
Descamps JL
Ann Pharm Fr; 1994; 52(6):294-302. PubMed ID: 7864529
[TBL] [Abstract][Full Text] [Related]
9. [Genetically engineered drugs and their application with the example of erythropoietin].
Donatz V; Zahner J
Anasthesiol Intensivmed Notfallmed Schmerzther; 2001 Jul; 36(7):440-4. PubMed ID: 11496621
[TBL] [Abstract][Full Text] [Related]
10. Challenges and opportunities in biotechnology.
Overby LR
Prog Clin Biol Res; 1985; 182():425-43. PubMed ID: 2994109
[TBL] [Abstract][Full Text] [Related]
11. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
12. An overview of biotechnology.
Demain AL
Occup Med; 1991; 6(2):157-68. PubMed ID: 2047970
[TBL] [Abstract][Full Text] [Related]
13. Food-processing enzymes from recombinant microorganisms--a review.
Olempska-Beer ZS; Merker RI; Ditto MD; DiNovi MJ
Regul Toxicol Pharmacol; 2006 Jul; 45(2):144-158. PubMed ID: 16769167
[TBL] [Abstract][Full Text] [Related]
14. The preclinical development of biotechnology-derived pharmaceuticals: the PMA perspective. Pharmaceutical Manufacturers Association.
Stoll RE
Prog Clin Biol Res; 1987; 235():169-71. PubMed ID: 3474669
[No Abstract] [Full Text] [Related]
15. The history and contemporary challenges of the US Food and Drug Administration.
Borchers AT; Hagie F; Keen CL; Gershwin ME
Clin Ther; 2007 Jan; 29(1):1-16. PubMed ID: 17379043
[TBL] [Abstract][Full Text] [Related]
16. Hydrocortisone made in yeast: metabolic engineering turns a unicellular microorganism into a drug-synthesizing factory.
Dumas B; Brocard-Masson C; Assemat-Lebrun K; Achstetter T
Biotechnol J; 2006 Mar; 1(3):299-307. PubMed ID: 16897710
[TBL] [Abstract][Full Text] [Related]
17. Flexibility--the guiding principle for antibody manufacturing.
Carson KL
Nat Biotechnol; 2005 Sep; 23(9):1054-8. PubMed ID: 16151390
[TBL] [Abstract][Full Text] [Related]
18. Biologicals and vaccines: regulatory perspectives.
Petricciani JC
Dev Biol Stand; 1986; 63():15-9. PubMed ID: 3743903
[TBL] [Abstract][Full Text] [Related]
19. Biotechnology: an overview of the tools, therapeutic agents, and applications to pharmacy practice.
Piascik P
Pharm Pract Manag Q; 1998 Jul; 18(2):1-12. PubMed ID: 10185234
[TBL] [Abstract][Full Text] [Related]
20. Regulatory issues for plant-made pharmaceuticals and vaccines.
Streatfield SJ
Expert Rev Vaccines; 2005 Aug; 4(4):591-601. PubMed ID: 16117714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
